(Q37840267)

24 August 2017

1 reference

title

Cardiovascular risk, drugs and erectile function--a systematic analysis (English)

1 reference

24 August 2017

M Baumhäkel

1

1 reference

24 August 2017

N Schlimmer

2

1 reference

24 August 2017

M Kratz

3

1 reference

24 August 2017

G Hackett

4

1 reference

24 August 2017

G Jackson

5

1 reference

24 August 2017

M Böhm

6

1 reference

24 August 2017

publication date

1 March 2011

1 reference

International Journal of Clinical Practice

24 August 2017

published in

1 reference

24 August 2017

volume

65

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

289-298

1 reference

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

The burden and extent of comorbid conditions in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction: the need to be evaluated, the right to be treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Cardiovascular aspects of sexual medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Endothelial function in patients with vasculogenic erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction after therapy with metoprolol: the Hawthorne effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Beta-blocker effects on sexual function in normal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Cardiovascular drug use and the incidence of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Beta 2-adrenergic stimulation of androgen production by cultured mouse testicular interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Effect of aldosterone on isolated human penile corpus cavernosum tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Safety of nifedipine GITS in stable angina: the ACTION trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Sexual dysfunction in hypertensive patients treated with losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Different effect of losartan and amlodipine on penile structures in male spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02563.X

10.1111/J.1742-1241.2010.02563.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference